Hara, Y. (2025) “Clinical Utility of Targeted Next-Generation Sequencing for Determining Human Epidermal Growth Factor Receptor 2 Status and Optimizing Targeted Therapy in Breast Cancer”, World Journal of Oncology [Preprint]. doi:10.14740/wjon2583.